VANCOUVER, BC / ACCESS Newswire / May 8, 2026 / Onco-Innovations Limited (CBOE CA:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H, WKN:A3EKSZ) ("Onco" or the "Company") announces that Nucro-Technics Inc.
Precision medicine, also known as personalised medicine, is transforming healthcare by providing tailored treatments to patients suffering from life-threatening conditions. We are all unique, and our ...
Chimeric antigen receptor (CAR) T-cell therapies hold great promise for the treatment of both hematologic cancers and solid cancers. However, they also pose unique challenges for bioanalysis. For ...
The move to large molecules in Pharma offers unparalleled opportunities to improve human health, however with this move comes new challenges for researchers shifting to biologics. To assist scientists ...
Pharmaceutical Technology® spoke with Steve Lowes, senior director of Scientific Affairs at IQVIA Laboratories, ahead of AAPS PharmSci 360 to discuss method validation of biomarker bioanalysis. To ...
BioAnalysis launches BASIS 2.0, its next-gen GMP-compliant AUC software for gene therapy. Higher throughput, one-click workflows and full regulatory compliance. We built BASIS 2.0 to dramatically ...
Bioanalytical is a field that uses various techniques to study biological samples and detect, measure, and analyze biological molecules. This field is crucial for a wide range of applications, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results